XOMA
XOMA
NASDAQ · Biotechnology

Xoma Royalty Corporation

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$30.61
+1.39 (+4.76%)
As of Mar 25, 3:15 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +30.7% upside
Low Target $30.13
Average Target $40.02
High Target $66.99
Current Price $30.61
Current
$30.61
Target
$40.02
$30.13 $40.02 avg $66.99
Scenario Analysis
Bear Case
$30.13
-1.6%
Low target
Base Case
$40.02
+30.7%
Avg target
Bull Case
$66.99
+118.9%
High target
Risk/Reward
75.8x
Highly favorable
Price in Context
52-Week High
$39.92
-23.3% from high
52-Week Low
$18.35
+66.8% from low
Target vs 52W High
$40.02
+0.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%